Home
Conditions
Klatskin Tumor

Clinical trial condition

Klatskin Tumor

Explore clinical trials studying Klatskin Tumor. Study availability and eligibility vary by location and protocol.

48 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Klatskin Tumor trial results

Recruiting

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

NCT06175845

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +20 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

Charite Berlin, Germany

University Medical Center Bonn, Germany

Clinic Chemnitz Chemnitz, Germany

View Trial Details

Recruiting

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

NCT06923475

Conditions: Adenocarcinoma, Borderline Resectable, Carcinoma, +9 more
Locations: Amsterdam University Medical Center Amsterdam, Netherlands

View Trial Details

Recruiting

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

NCT07717437

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Rush University Medical Center Chicago, Illinois, United States

Mayo Clinic Rochester, Minnesota, United States

Cleveland Clinic Cleveland, Ohio, United States

Monash Medical Centre Clayton, Victoria, Australia

View all 31 locations

View Trial Details

Recruiting

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

NCT07614061

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
Locations: Shanghai Zhongshan Hospital, Fudan University Shanghai, China

View Trial Details

Recruiting

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

NCT05546372

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Amsterdam UMC location VUmc Amsterdam, Netherlands

View Trial Details

Recruiting

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

NCT07030140

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +13 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

NCT06125769

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Azienda Ospedale Università di Padova Padova, PADOVA, Italy

View Trial Details

Recruiting

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

NCT05430698

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

NCT07176962

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
Locations: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria

NCT06850753

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Klatskin Tumor

Klatskin Tumor trial results

Related conditions